Freshfields advised Merz Therapeutics on its $185 million acquisition of Acorda Therapeutics. Merz Therapeutics, a renowned entity in the neurotoxins sector, has entered into an agreement...
You must be a Standard 1 Year member to access this content.
Freshfields Advised Zeus on on the sale to EQT Private Equity. EQT X and Zeus Company, Inc., jointly announced that they have entered into a definitive...
You must be a Standard 1 Year member to access this content.
Freshfields advised Roivant on Sale of Telavant to Roche. Switzerland’s Roche (ROG.S) has entered into an agreement to pay an initial $7.1 billion to Roivant (ROIV.O)...
You must be a Standard 1 Year member to access this content.
